Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 18:16:1604271.
doi: 10.3389/fimmu.2025.1604271. eCollection 2025.

Research progress of SOCS in autoimmune diseases: mechanisms and therapeutic implications

Affiliations
Review

Research progress of SOCS in autoimmune diseases: mechanisms and therapeutic implications

Rongqi Cui et al. Front Immunol. .

Abstract

Suppressor of cytokine signaling (SOCS) is a family of regulatory factors whose expression can be induced by various cytokines, growth factors, and hormones. Autoimmune diseases, chronic inflammatory conditions caused by abnormal immune responses, involve overactive T-cells and B-cells, excessive autoantibody production, and damage to multiple organs and systems. The pathogenic mechanisms of autoimmune diseases are complex, and SOCS proteins, particularly SOCS1, SOCS2, SOCS3, and SOCS5, regulate cytokine receptor signaling through distinct mechanisms, thereby participating in the development and progression of autoimmune diseases. This positions SOCS proteins as potential therapeutic targets for modulating dysregulated immune responses in autoimmune diseases.

Keywords: JAK-STAT; SOCS; autoimmune diseases; cytokines; immunity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Structure of SOCS domain.
Figure 2
Figure 2
STAT-induced SOCS family proteins’ regulation of signal transduction.

Similar articles

References

    1. Davidson A, Diamond B. Autoimmune diseases. New Engl J Med. (2001) 345:340–50. doi: 10.1056/nejm200108023450506, PMID: - DOI - PubMed
    1. Liau NPD, Laktyushin A, Lucet IS, Murphy JM, Yao S, Whitlock E, et al. The molecular basis of JAK/STAT inhibition by SOCS1. Nat Commun. (2018) 9:1558. doi: 10.1038/s41467-018-04013-1, PMID: - DOI - PMC - PubMed
    1. Toghi M, Taheri M, Arsang-Jang S, Ohadi M, Mirfakhraie R, Mazdeh M, et al. SOCS gene family expression profile in the blood of multiple sclerosis patients. J neurological Sci. (2017) 375:481–5. doi: 10.1016/j.jns.2017.02.015, PMID: - DOI - PubMed
    1. Ni R, Ihara K, Miyako K, Takemoto M, Ishimura M, Kohno H, et al. Association study of polymorphisms in SOCS family genes with type 1 diabetes mellitus. Int J immunogenetics. (2006) 33:7–10. doi: 10.1111/j.1744-313X.2006.00563.x, PMID: - DOI - PubMed
    1. Conforti A, Di Cola I, Pavlych V, Ruscitti P, Berardicurti O, Ursini F, et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev. (2021) 20:102735. doi: 10.1016/j.autrev.2020.102735, PMID: - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources